Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

LMA De Strooper, J Berkhof… - … journal of cancer, 2018 - Wiley Online Library
DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has
shown a good clinical performance in detecting cervical cancer and advanced CIN lesions …

HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women

MT Bruno, M Ferrara, V Fava, A Rapisarda, A Coco - Virology journal, 2018 - Springer
Background Clinical management of HPV positive women is difficult since many of the
infections, including high-risk oncogene genotypes (hr-HPV), are transient. Therefore only a …

Diagnostic utility of HPV16 E6 mRNA or E7 mRNA quantitative expression for cervical cells of patients with dysplasia and carcinoma

MZ Wu, WN Li, N Cha, LX Tian, YI Zhang… - Cell …, 2018 - journals.sagepub.com
Current human papillomavirus (HPV) 16 DNA testing has high sensitivity but low specificity,
while mRNA testing (qualitative) improves the specificity. However, both techniques are not …

Aptima human papillomavirus E6/E7 mRNA test results strongly associated with risk for high-grade cervical lesions in follow-up biopsies

Y Ge, P Christensen, E Luna, D Armylagos… - Journal of Lower …, 2018 - journals.lww.com
Objective Human papillomavirus (HPV) tests and genotyping (GT) have been used in
clinical risk assessment. The purpose of this study was to analyze the performance of 2 …

Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or with Abnormal …

L Han, S Husaiyin, M Niyazi, F Zhao… - Clinical …, 2018 - search.ebscohost.com
Background: The detection of human papillomavirus (HPV) E6/E7 mRNA indicates a risk of
further deterioration in cervical lesions. We explored the clinical value of HPV E6/E7 mRNA …

Quantification of HPV16 E6/E7 mRNA spliced isoforms viral load as a novel diagnostic tool for improving cervical cancer screening

C Camus, S Vitale, C Loubatier, G Penaranda… - Journal of Clinical …, 2018 - mdpi.com
High-risk human papillomaviruses (HPVs) have been identified as the main contributors to
cervical cancer. Despite various diagnostic tools available, including the predominant …

HPV mRNA 联合液基细胞学检查对中年宫颈癌前病变筛查结果分析.

高雪莲 - Journal of Modern Medicine & Health, 2018 - search.ebscohost.com
目的分析人乳头状瘤病毒(HPV) 联合液基细胞学检查对中年宫颈癌前病变的筛查结果.
方法收集2013 年2 月至2016 年5 月该院宫颈液基细胞学检查标本1 982 例, 宫颈HPV mRNA …

[HTML][HTML] The potential of RNA as a target for national screening of pre-cancer

F Karlsen, M Muturi, C Muyabwa… - Journal of Public …, 2018 - ncbi.nlm.nih.gov
Whole national screening of pre-cancer is done only in some few countries, dominated by
The Netherlands, Denmark, UK, Norway and Finland. These national screenings are done …

Clinical value of human papillomavirus E6/E7 mRNA testing in patients with atypical squamous cells of undetermined significance and low-grade squamous …

Q Wang, CY Zhu, LM Chen, SJ Gao, M Du… - Reproductive and …, 2018 - mednexus.org
Objective: To explore the clinical significance of the quantitative detection of human
papillomavirus (HPV) E6/E7mRNA in triage of patients with atypical squamous cells of …

Acurácia do teste de RNAm HPV comopreditor derecidivade lesões intraepiteliais de alto grau e câncer de colo uterino após conização: revisão sistemática e …

CDLM Borba - 2018 - repositorio.unesc.net
Introdução: O câncer de colo uterino, apesar de ser uma das patologias malignas de fácil
rastreio e prevenção, ainda é um importante problema na saúde coletiva. É responsável por …